Here is a link to the latest article by Kirsty Duncan:

http://www.ipolitics.ca/2012/10/27/kirsty-duncan-double-standard-in-medical-care-applies-to-canadians-with-ms/

Here are a couple of questions she asks in the article, first regarding the voice of people with MS not being heard:

The Conservative-dominated Senate committee continues to refuse to hear from those who have multiple sclerosis (MS). Can anyone imagine a committee silencing a cancer patient, a heart patient or someone living in poverty? Why, then, are MS patients and a well-known Canadian CCSVI expert, Dr. Sandy McDonald, being silenced? Why is the government shutting down these important voices?

and secondly regarding the negative bias aimed at CCSVI treatment:

As Anne Kingston explained in her February 29 article in Comma in Maclean’s, “The medical politics blocking CCSVI trials”, the kidney denervation study was not double-blinded, and it was bankrolled by Adrian Inc., the American company that developed the $US 6,000.00 catheter used in the procedure.

The question that begs to be asked is why Health Canada approved renal denervation surgery under its access to care program when the one study of its safety and efficacy was based on was the company making the catheters used in the procedure? Yet again, a real dichotomy in the way CCSVI has been treated  compared to other procedures. The only conclusion that can be drawn is that a double-standard in medical care applies to Canadians with MS.

The whole article is worth a read though...